These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17455191)

  • 1. HTS, chemical hybridization, and drug design identify a chemically unique antituberculosis agent-coupling serendipity and rational approaches to drug discovery.
    Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    ChemMedChem; 2007 Jun; 2(6):811-3. PubMed ID: 17455191
    [No Abstract]   [Full Text] [Related]  

  • 2. From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters.
    Mao J; Yuan H; Wang Y; Wan B; Pieroni M; Huang Q; van Breemen RB; Kozikowski AP; Franzblau SG
    J Med Chem; 2009 Nov; 52(22):6966-78. PubMed ID: 19863050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and pharmacological evaluation of mefloquine-based ligands as novel antituberculosis agents.
    Mao J; Wang Y; Wan B; Kozikowski AP; Franzblau SG
    ChemMedChem; 2007 Nov; 2(11):1624-30. PubMed ID: 17680579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
    Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
    Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv.
    Sunduru N; Gupta L; Chaturvedi V; Dwivedi R; Sinha S; Chauhan PM
    Eur J Med Chem; 2010 Aug; 45(8):3335-45. PubMed ID: 20452706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
    Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
    Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel anti-tuberculosis agents from MCR libraries.
    Dömling A; Achatz S; Beck B
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5483-6. PubMed ID: 17720495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of antitubercular activity of glycosyl thio- and sulfonyl acetamide derivatives.
    Ghosh S; Tiwari P; Pandey S; Misra AK; Chaturvedi V; Gaikwad A; Bhatnagar S; Sinha S
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4002-5. PubMed ID: 18579372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
    Braendvang M; Bakken V; Gundersen LL
    Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of substituents on diarylmethanes for antitubercular activity.
    Panda G; Parai MK; Das SK; Shagufta ; Sinha M; Chaturvedi V; Srivastava AK; Manju YS; Gaikwad AN; Sinha S
    Eur J Med Chem; 2007 Mar; 42(3):410-9. PubMed ID: 17112639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity.
    Bedia KK; Elçin O; Seda U; Fatma K; Nathaly S; Sevim R; Dimoglo A
    Eur J Med Chem; 2006 Nov; 41(11):1253-61. PubMed ID: 16919372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development.
    Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin analogs.
    Manna K; Agrawal YK
    Eur J Med Chem; 2010 Sep; 45(9):3831-9. PubMed ID: 20576327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-tubercular activity of novel alkyl substituted riminophenazine derivatives.
    Li YL; Zhang CL; Zhang DF; Lu Y; Wang B; Zheng MQ; Li C; Yin DL; Huang HH
    Yao Xue Xue Bao; 2012 Jun; 47(6):745-54. PubMed ID: 22919722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
    Gasse C; Douguet D; Huteau V; Marchal G; Munier-Lehmann H; Pochet S
    Bioorg Med Chem; 2008 Jun; 16(11):6075-85. PubMed ID: 18467107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis and antituberculosis activity of 5'-nor carbocyclic uracil derivatives.
    Matyugina E; Khandazhinskaya A; Chernousova L; Andreevskaya S; Smirnova T; Chizhov A; Karpenko I; Kochetkov S; Alexandrova L
    Bioorg Med Chem; 2012 Nov; 20(22):6680-6. PubMed ID: 23062712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives.
    Gonçalves RS; Kaiser CR; Lourenço MC; de Souza MV; Wardell JL; Wardell SM; da Silva AD
    Eur J Med Chem; 2010 Dec; 45(12):6095-100. PubMed ID: 20932608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM; El-Koussi NA; Hassan HY
    Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.